Assessing Benefit, Risk, and a Benefit-Risk Balance

Venue: Philadelphia

Location: Philadelphia, United States

Event Date/Time: Oct 18, 2004 End Date/Time: Oct 19, 2004
Report as Spam


Does your company know how to assess risk and benefit? And can you communicate that information effectively? Most companies struggle with these critical issues. Here’s your chance to dramatically improve your ability to assess both risk and benefit, ultimately leading to higher sales and lower liabilities.

Register now to guarantee a spot at this conference. Don’t miss this unique conference touching issues that other risk-related conferences don’t address.

Save $200 by registering for this conference and PEA’s 3RD Annual Risk Management conference on December 8-10, 2004 in Philadelphia, PA.

Why should you attend this conference? Consider this typical comment from a Pharma-exec facing a difficult NDA:

“I am responsible for a product in the same class as [another drug made by a different company]. That drug is on the market under a very restrictive risk management program which has proven a barrier to physicians who would otherwise prescribe the product. During their RMP update, the FDA continued to focus only on risks and the company failed to present a strong benefit-oriented case. The result was an unwillingness to modify the RMP. Our case to the FDA must be sufficiently compelling and data-driven or we will end up in the same restrictive box…”

This conference is specially designed to help you solve thorny problems like this one. Be sure to register now while your need for this conference is fresh in mind.